BHC
BHC
NYSE · Pharmaceuticals

Bausch Health Cos Inc

$5.67
+0.02 (+0.35%)
As of Sep 20, 10:02 PM ET ·
Analyst Consensus
Strong Sell
8
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 50%
Sell 4 50%
Price Target
Analyst Price Target +1,730.3% upside
Low Target $65.08
Average Target $103.78
High Target $115.24
Current Price $5.67
Current
$5.67
Target
$103.78
$65.08 $103.78 avg $115.24
Scenario Analysis
Bear Case
$65.08
1,047.8%
Low target
Base Case
$103.78
+1,730.3%
Avg target
Bull Case
$115.24
+1,932.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.08
-48.8% from high
52-Week Low
$6.10
+-7.0% from low
50-Day SMA
$6.64
-14.6% vs SMA
200-Day SMA
$6.36
-10.8% vs SMA
RSI (14)
60.0
Neutral
Target vs 52W High
$103.78
+836.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%